The ups and downs of p53: understanding protein dynamics in single cells

E Batchelor, A Loewer, G Lahav - Nature Reviews Cancer, 2009 - nature.com
Cells living in a complex environment must constantly detect, process and appropriately
respond to changing signals. Therefore, all cellular information processing is dynamic in …

MDM2 SNP309 and cancer risk: a combined analysis

S Wilkening, JL Bermejo, K Hemminki - Carcinogenesis, 2007 - academic.oup.com
A paper by Bond et al. reported that a single-nucleotide polymorphism (SNP) in the intronic
promoter region of the mouse double minute 2 (MDM2) gene (called SNP309) can …

MDM2 Promoter Polymorphism SNP309 Contributes to Tumor Susceptibility: Evidence from 21 Case-Control Studies

Z Hu, G Jin, L Wang, F Chen, X Wang, H Shen - … Epidemiology Biomarkers & …, 2007 - AACR
Since the identification of a well-characterized functional polymorphism named SNP309 in
MDM2, abundant studies were published in the last 2 years to evaluate the association …

Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium

MK Schmidt, S Reincke, A Broeks, LM Braaf… - Cancer research, 2007 - AACR
Association studies in large series of breast cancer patients can be used to identify single-
nucleotide polymorphisms (SNP) contributing to breast cancer susceptibility. Previous …

Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis

KP Economopoulos, TN Sergentanis - Breast cancer research and …, 2010 - Springer
MDM2 SNP309 is a single nucleotide T> G polymorphism present in intron 1 of the MDM2
gene. A variety of case–control studies have been published evaluating the association …

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

Y Wan, W Wu, Z Yin, P Guan, B Zhou - BMC cancer, 2011 - Springer
Background The tumor suppressor gene p53 is involved in multiple cellular pathways
including apoptosis, transcriptional control, and cell cycle regulation. In the last decade it …

Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women

V Singh, N Rastogi, N Mathur, K Singh, MP Singh - Annals of epidemiology, 2008 - Elsevier
PURPOSE: Single nucleotide polymorphism (SNP) at position− 309 (T309G) in MDM-2
promoter induces tumor formation in the individuals possessing inherited p53 mutations …

MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population

SS Lum, HW Chua, H Li, WF Li, N Rao, J Wei… - …, 2008 - academic.oup.com
Sporadic breast cancer in women< 40 years is uncommon in Caucasians, in contrast to a
much earlier onset in Chinese Asians. However, the molecular determinants for this earlier …

Recent advances in validating MDM2 as a cancer target

ER Rayburn, SJ Ezell, R Zhang - Anti-Cancer Agents in …, 2009 - ingentaconnect.com
The MDM2 oncogene is overexpressed in various human cancers. Its expression correlates
with the phenotypes of high-grade, late-stage, and more resistant tumors. The auto …

MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism

FEM Paulin, M O'Neill, G McGregor, A Cassidy… - BMC cancer, 2008 - Springer
Introduction A functional polymorphism within MDM2, SNP309 T> G, has been linked to
early onset cancer. This study examined clinical associations of breast cancer with SNP309 …